Shareholder Alert: The Ademi Firm investigates whether Performant Healthcare Inc. is obtaining a Fair Price for its Public Shareholders
4 augusti, 16:00
4 augusti, 16:00
Shareholder Alert: The Ademi Firm investigates whether Performant Healthcare Inc. is obtaining a Fair Price for its Public Shareholders
PR Newswire
MILWAUKEE, Aug. 4, 2025
MILWAUKEE , Aug. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating Performant (NASDAQ: PHLT) for possible breaches of fiduciary duty and other violations of law in its transaction with Machinify .
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.
In the transaction, shareholders of Performant will receive $7.75 in cash for each share of common stock outstanding, or approximately $670 million in the aggregate. Performant insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Performant by imposing a significant penalty if Performant accepts a competing bid. We are investigating the conduct of the Performant board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi LLP
4 augusti, 16:00
Shareholder Alert: The Ademi Firm investigates whether Performant Healthcare Inc. is obtaining a Fair Price for its Public Shareholders
PR Newswire
MILWAUKEE, Aug. 4, 2025
MILWAUKEE , Aug. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating Performant (NASDAQ: PHLT) for possible breaches of fiduciary duty and other violations of law in its transaction with Machinify .
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.
In the transaction, shareholders of Performant will receive $7.75 in cash for each share of common stock outstanding, or approximately $670 million in the aggregate. Performant insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Performant by imposing a significant penalty if Performant accepts a competing bid. We are investigating the conduct of the Performant board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi LLP
Novo Nordisk
Aktieråd
Analys
Bostadsmarknaden
Novo Nordisk
Aktieråd
Analys
Bostadsmarknaden
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 562,75